IL165763A0 - Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives - Google Patents

Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives

Info

Publication number
IL165763A0
IL165763A0 IL16576304A IL16576304A IL165763A0 IL 165763 A0 IL165763 A0 IL 165763A0 IL 16576304 A IL16576304 A IL 16576304A IL 16576304 A IL16576304 A IL 16576304A IL 165763 A0 IL165763 A0 IL 165763A0
Authority
IL
Israel
Prior art keywords
sub
oxazol
preparing
benzoic acid
acid derivatives
Prior art date
Application number
IL16576304A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Ltd filed Critical Pharmacia & Upjohn Co Ltd
Publication of IL165763A0 publication Critical patent/IL165763A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
IL16576304A 2002-06-20 2004-12-14 Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives IL165763A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (1)

Publication Number Publication Date
IL165763A0 true IL165763A0 (en) 2006-01-15

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16576304A IL165763A0 (en) 2002-06-20 2004-12-14 Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives

Country Status (18)

Country Link
US (2) US7115747B2 (xx)
EP (1) EP1532123B1 (xx)
JP (1) JP2005533811A (xx)
CN (1) CN1324017C (xx)
AT (1) ATE370131T1 (xx)
AU (1) AU2003249344A1 (xx)
BR (1) BR0312439A (xx)
CA (1) CA2489988A1 (xx)
CO (1) CO5670350A2 (xx)
DE (1) DE60315664D1 (xx)
EA (1) EA008389B1 (xx)
HK (1) HK1081543A1 (xx)
IL (1) IL165763A0 (xx)
MX (1) MXPA04012630A (xx)
NO (1) NO20045497L (xx)
NZ (1) NZ537390A (xx)
PL (1) PL374999A1 (xx)
WO (1) WO2004000821A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565428A1 (en) * 2002-11-27 2005-08-24 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7838676B2 (en) 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
AU2006316620B2 (en) 2005-11-21 2011-03-03 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
WO2008137954A2 (en) * 2007-05-07 2008-11-13 Environmental Packaging Technologies Limited Universal shipping container
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
WO2008147547A1 (en) 2007-05-25 2008-12-04 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
PE20110805A1 (es) 2008-09-11 2011-11-09 Amgen Inc Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso
US9296698B2 (en) 2009-11-23 2016-03-29 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
EP2504330A1 (en) 2009-11-23 2012-10-03 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
CA2788363A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011115938A1 (en) 2010-03-15 2011-09-22 Amgen Inc. Spiro-tetracyclic ring compounds as beta - secretase modulators
US8497264B2 (en) 2010-03-15 2013-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
WO2012109165A1 (en) 2011-02-07 2012-08-16 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2462851A1 (en) 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
MXPA04004428A (es) * 2001-11-08 2004-09-10 Elan Pharm Inc Derivados de 2,3-diamino-2-hidroxipropano n,n`-sustituidos.
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20040063965A1 (en) 2004-04-01
NZ537390A (en) 2006-07-28
AU2003249344A1 (en) 2004-01-06
JP2005533811A (ja) 2005-11-10
NO20045497D0 (no) 2004-12-16
ATE370131T1 (de) 2007-09-15
EA008389B1 (ru) 2007-04-27
BR0312439A (pt) 2005-05-10
EA200401510A1 (ru) 2005-06-30
CA2489988A1 (en) 2003-12-31
PL374999A1 (en) 2005-11-14
EP1532123A1 (en) 2005-05-25
NO20045497L (no) 2005-03-07
US7115747B2 (en) 2006-10-03
DE60315664D1 (de) 2007-09-27
US20070105921A1 (en) 2007-05-10
MXPA04012630A (es) 2005-09-30
CO5670350A2 (es) 2006-08-31
HK1081543A1 (en) 2006-05-19
CN1662510A (zh) 2005-08-31
EP1532123B1 (en) 2007-08-15
CN1324017C (zh) 2007-07-04
WO2004000821A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
HK1081543A1 (en) Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
MY142768A (en) Gfat inhibitors
MY142807A (en) Benzimidazole derivative and use thereof.
WO2004094384A3 (en) (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
EP1740559A4 (en) 1,3,5-SUBSTITUTED PHENYL DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EA200101194A1 (ru) Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
HK1125358A1 (en) Substituted cyclohexylmethyl derivatives
WO2003103653A8 (en) METHODS OF TREATING ALZHEIMER'S DISEASE WITH ALKANOIC ARYL ACID AMIDES
TW200505418A (en) Phenacyl 2-hydroxy-3-diaminoalkanes
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
EA200500006A1 (ru) Лекарственное средство для лечения нейродегенеративных заболеваний
PT2113502E (pt) Compostos do tipo hidrazida e sua utilização em composições farmacêuticas para o tratamento das doenças cardiovasculares
PL1685142T3 (pl) Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera
AU2003242144A1 (en) Processes for producing epoxytriazole derivative and intermediate therefor
TW200637856A (en) Process for producing thiazolidinedion compound and intermediate thereof
EP1036793A3 (en) A process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
TW200612912A (en) Benzyloxy derivatives as maob inhibitors
MXPA05009122A (es) Derivados de acido benzoilureidopiridil-piperidin-y pirrolidin-carboxilico sustituido, metodo para su produccion y su uso.
MXPA05013732A (es) Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo.
WO2004032854A3 (en) Pharmaceutical compositions for treatment of parkinson's disease
MXPA05007217A (es) Proceso para la preparacion de derivados de imidazol sustituidos y los productos intermedios usados en este proceso.